Motley Fool Asset Management LLC Buys 54,394 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV)

Motley Fool Asset Management LLC boosted its stake in Shockwave Medical, Inc. (NASDAQ:SWAV) by 577.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,807 shares of the company’s stock after purchasing an additional 54,394 shares during the period. Motley Fool Asset Management LLC owned about 0.17% of Shockwave Medical worth $12,159,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Lindbrook Capital LLC increased its position in shares of Shockwave Medical by 64.8% during the third quarter. Lindbrook Capital LLC now owns 150 shares of the company’s stock worth $30,000 after buying an additional 59 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Shockwave Medical by 297.4% in the third quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock worth $31,000 after purchasing an additional 116 shares during the period. Asset Management One Co. Ltd. acquired a new stake in Shockwave Medical in the fourth quarter worth $34,000. Operose Advisors LLC acquired a new stake in Shockwave Medical in the third quarter worth $49,000. Finally, Venturi Wealth Management LLC acquired a new stake in Shockwave Medical in the third quarter worth $82,000. Institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on SWAV shares. Wells Fargo & Company raised their price target on shares of Shockwave Medical from $200.00 to $210.00 and gave the stock an “equal weight” rating in a report on Friday, February 16th. Leerink Partnrs cut shares of Shockwave Medical from an “outperform” rating to a “market perform” rating in a report on Friday, April 5th. Canaccord Genuity Group reiterated a “hold” rating and set a $335.00 price objective (up from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. Piper Sandler lifted their price objective on shares of Shockwave Medical from $290.00 to $360.00 and gave the company an “overweight” rating in a report on Tuesday, April 2nd. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Shockwave Medical in a report on Friday, April 5th. Ten investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $309.11.

Insiders Place Their Bets

In other Shockwave Medical news, VP Trinh Phung sold 599 shares of Shockwave Medical stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $259.24, for a total value of $155,284.76. Following the sale, the vice president now owns 31,031 shares of the company’s stock, valued at $8,044,476.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $224.69, for a total value of $898,760.00. Following the completion of the transaction, the insider now owns 63,920 shares in the company, valued at $14,362,184.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Trinh Phung sold 599 shares of Shockwave Medical stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $259.24, for a total transaction of $155,284.76. Following the completion of the transaction, the vice president now owns 31,031 shares of the company’s stock, valued at approximately $8,044,476.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 93,813 shares of company stock valued at $23,762,679. Company insiders own 3.40% of the company’s stock.

Shockwave Medical Stock Up 0.0 %

Shares of SWAV traded up $0.12 during trading hours on Thursday, reaching $328.99. 597,448 shares of the stock traded hands, compared to its average volume of 959,437. The company has a current ratio of 11.76, a quick ratio of 10.73 and a debt-to-equity ratio of 1.09. The stock has a fifty day simple moving average of $293.53 and a 200 day simple moving average of $232.36. Shockwave Medical, Inc. has a 52 week low of $157.00 and a 52 week high of $331.58. The company has a market cap of $12.30 billion, a price-to-earnings ratio of 85.01, a PEG ratio of 2.44 and a beta of 0.92.

Shockwave Medical (NASDAQ:SWAV) last released its quarterly earnings results on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.24. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The company had revenue of $202.98 million for the quarter, compared to analyst estimates of $199.43 million. During the same period last year, the firm earned $3.71 earnings per share. The firm’s revenue was up 41.0% on a year-over-year basis. On average, equities analysts forecast that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

About Shockwave Medical

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.